Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC069499.1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | AC074141.1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | AC084219.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC087350.1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | AC090154.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | AC092835.2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | AC138969.4 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | AC231657.1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | AC240274.1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | ACAA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |